Cargando…

α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease

AIM: Antioxidant therapy for with vitamin E appears to be effective for the treatment of nonalcoholic fatty liver disease　(NAFLD). However, the mechanism of action and optimal therapeutic dosage is unclear. The present study was undertaken to examine whether the effects of α‐tocopherol (α‐Toc) on NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokoro, Masanori, Gotoh, Koro, Kudo, Yoko, Hirashita, Yuka, Iwao, Masao, Arakawa, Mie, Endo, Mizuki, Oribe, Junya, Masaki, Takayuki, Honda, Koichi, Kakuma, Tetsuya, Seike, Masataka, Murakami, Kazunari, Shibata, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909598/ https://www.ncbi.nlm.nih.gov/pubmed/33680496 http://dx.doi.org/10.1002/osp4.460

Ejemplares similares

Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid
por: Iwao, Masao, et al.
Publicado: (2020)

Maximum Plasma Concentration of Lenvatinib Is Useful for Predicting Thrombocytopenia in Patients Treated for Hepatocellular Carcinoma
por: Endo, Mizuki, et al.
Publicado: (2021)

Tocilizumab-induced mucosal injury in the terminal ileum mimicking intestinal Behçet’s disease: A case report
por: Ozaka, Sotaro, et al.
Publicado: (2023)

A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and Liver
por: Gotoh, Koro, et al.
Publicado: (2012)

Acute Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis That Responded to Glucocorticoid Therapy
por: Ozaka, Sotaro, et al.
Publicado: (2022)

Glucagon-like peptide-1 reduces pancreatic β-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats
por: Ando, Hisae, et al.
Publicado: (2017)

Spleen-Derived Interleukin-10 Downregulates the Severity of High-Fat Diet-Induced Non-Alcoholic Fatty Pancreas Disease
por: Gotoh, Koro, et al.
Publicado: (2012)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

Hypothalamic neuronal histamine mediates the thyrotropin-releasing hormone-induced suppression of food intake(1)
por: Gotoh, Koro, et al.
Publicado: (2007)

Oral Salt Loading Test is Associated With 24-Hour Blood Pressure and Organ Damage in Primary Aldosteronism Patients
por: Yoshida, Yuichi, et al.
Publicado: (2020)

Quantitative proteomics reveals Polygonum perfoliatum L. ameliorates hepatic steatosis by promoting PPARs/CPT1A/CPT2-mediated fatty acid β-oxidation
por: Liu, Guanjie, et al.
Publicado: (2023)

Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury
por: Donde, Hridgandh, et al.
Publicado: (2019)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

The Dipeptidyl Peptidase-4 Inhibitor Des-Fluoro-Sitagliptin Regulates Brown Adipose Tissue Uncoupling Protein Levels in Mice with Diet-Induced Obesity
por: Shimasaki, Takanobu, et al.
Publicado: (2013)

Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion
por: Ozeki, Yoshinori, et al.
Publicado: (2022)

Fulminant type 1 diabetes mellitus with anti‐programmed cell death‐1 therapy
por: Okamoto, Masahide, et al.
Publicado: (2016)

Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease's Statin Therapy in Men
por: Hadzi-Petrushev, Nikola, et al.
Publicado: (2018)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice
por: Wang, Peng, et al.
Publicado: (2023)

CPT and Superstring
por: Ellis, John R., et al.
Publicado: (1996)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
por: Pirozzi, Anna Virginia Adriana, et al.
Publicado: (2020)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
por: Choi, Naeun, et al.
Publicado: (2019)

Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis
por: Jiang, Wenjiao, et al.
Publicado: (2020)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

CP, T and CPT at CPLEAR
por: Filipcic, Andrej, et al.
Publicado: (2001)

Tests of CPT with CPLEAR
por: Mikuz, M
Publicado: (2000)

Tests of CPT with CPLEAR
por: Adler, R, et al.
Publicado: (1996)

Test of CPT with antiprotons
por: Poth, Helmut
Publicado: (1978)

Cold antihydrogen and CPT
por: Gabrielse, G, et al.
Publicado: (2002)

Mechanism for CPT violation
por: Klinkhamer, F R
Publicado: (2001)

T and CPT in B-Factories
por: Bernabeu, J, et al.
Publicado: (2001)

Tests of CPT and CPT from neutral kaon semileptonic decays at the CPLEAR experiment
por: Go, Apollo Tao-ning
Publicado: (1995)

RRR-α-Tocopherol Is the Predominant Stereoisomer of α-Tocopherol in Human Milk
por: Kuchan, Matthew J, et al.
Publicado: (2018)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
por: Pirmoazen, Amir M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ss8jek6d7q00u4d2bvc7lbq5lg